{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"71","value":"33"},{"groupId":"OG001","lowerLimit":"40","upperLimit":"82","value":"61"},{"groupId":"OG002","lowerLimit":"33","upperLimit":"57","value":"45"},{"groupId":"OG003","lowerLimit":"27","upperLimit":"51","value":"39"},{"groupId":"OG004","lowerLimit":"16","upperLimit":"75","value":"46"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"65"},{"groupId":"OG004","value":"11"}],"units":"Participants"}],"description":"Assessed using the product-limit based Kaplan Meier method.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients diagnosed with and treated for acute myeloid leukemia or acute lymphoblastic leukemia","id":"OG000","title":"Acute Leukemia"},{"description":"Patients diagnosed with and treated for Hodgkin Lymphoma","id":"OG001","title":"Hodgkin Lymphoma"},{"description":"Patients diagnosed with and treated for Non-Hodgkin Lymphoma","id":"OG002","title":"Non-Hodgkin Lymphoma"},{"description":"Patients diagnosed with or treated for multiple myeloma or amyloidosis","id":"OG003","title":"MM/Amyloid"},{"description":"Patients diagnosed with and treated for a solid tumor","id":"OG004","title":"Solid Tumors"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Patients are followed up to maximum of 12 years","title":"Overall Survival, Presented as the Estimate at 10-yrs (Median Follow-up Time in Survivors)","type":"SECONDARY","unitOfMeasure":"Proportion of participants"}